MLXIPL and type 2 diabetes mellitus: MCE decreased the protein and mRNA expression levels of SREBP-1c and ChREBP, which indicates the protective effect of MCE on hepatic injury that commonly occurs with type 2 diabetes mellitus (T2DM).